Latest

SARS-CoV-2

·April 18, 2020·3 min read

Individual genetic variation in immune system may affect severity of COVID-19

Study reveals genetic variability in the immune system could affect susceptibility to coronavirus infection and govern the severity of the disease for those infected.

Featured Neuroscience Open Neuroscience Articles

·April 18, 2020·2 min read

WHO recommended disinfectants are easy to make and effective against COVID-19

Are you finding it hard to find hand sanitizers in the wake of COVID-19? The WHO has provided a recommended formula to make your own hand disinfectants that can kill the SARS-CoV-2 virus within 30 seconds.

Featured Neuroscience

·April 17, 2020·4 min read

COVID-19 striking more children than expected

Researchers report the number of children infected with COVID-19 is far more extensive than being reported. For every child that requires hospitalization and ICU care for coronavirus, there are 2,381 other children infected with the virus.

This shows toilet paper and a surgical mask

Featured Neuroscience

·April 17, 2020·4 min read

Gastrointestinal symptoms common in COVID-19 patients

31.9% of COVID-19 patients reported experiencing gastrointestinal problems as a result of their infection. 22% reported a loss of appetite, with an additional 22% reporting nausea and vomiting, and 12% reported diarrhea. 40% of patients had elevated levels of an abnormal liver enzyme.

Featured Neuroscience Psychology

·April 17, 2020·2 min read

Stress related to catching COVID-19 is highest among 30-59 year-olds

Stress and anxiety about catching coronavirus are more prevalent among the 30-59-year-old age group.

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020·3 min read

Researchers sample sewage to measure COVID-19 infections in six European countries

Researchers are tracking the sewage systems in six European countries to measure the spread of COVID-19. The system will remain in place, providing an early warning for the second wave of potential coronavirus infections.

Featured Neuroscience

·April 16, 2020·4 min read

Investigational Remdesivir therapy gaining reputation as promising COVID-19 antiviral

Researchers conducting a clinical trial of Remdesivir to treat coronavirus report the drug appears to be promising. The drug, initially designed to treat Ebola, is well tolerated, and patients treated with the drug are showing signs of recovery. Early indications suggest Remdesivir could stave off the need for intubating patients suffering from COVID-19.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 16, 2020·3 min read

Impaired Blood Clotting May Explain Higher COVID-19 Risk

Higher levels of plasmin, an enzyme involved in blood clotting prevention, enhances the virulence and infectivity of SARS-CoV-2 by cleaving its spike proteins. Enhanced levels of plasmin are common in a range of diseases, including diabetes and heart disease. The findings shed light on why those with hypertension and diabetes are at increased risk of complications following coronavirus infection.

This shows a woman in a facemask looking worried

Featured Neuroscience Psychology

·April 16, 2020·2 min read

US adults are most concerned about experiencing increased anxiety as a result of COVID-19

As many as two in five Americans report concerns about experiencing increased anxiety in the wake of coronavirus. 68% of people feel like everything is out of their control. 38% of Americans report feeling optimistic about the country's recovery, believing we will come out of the pandemic stronger than before.

Featured Neurology Neuroscience Neuroscience Videos Open Neuroscience Articles

·April 16, 2020·4 min read

Researchers investigate overactive immune cells as cause of COVID-19 deaths

Study investigates whether overactive immune cells that produce neutrophil extracellular traps (NETs) are responsible for more severe and lethal cases of coronavirus.

Featured Genetics Neuroscience

·April 16, 2020·3 min read

Proteins may halt the severe cytokine storms seen in COVID-19 patients

Researchers have designed antibody-like receptor proteins that can bind to cytokines, possibly reducing the effects of the COVID-19 associated cytokine storm.

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020·3 min read

Development of antibody research may help prevent sepsis induced by COVID-19

Researchers have developed a novel antibody strategy to prevent the association between a harmless protein and a disease mediator that could lead to sepsis, and ultimately death. The findings could help to prevent sepsis induced by COVID-19 infections.